REcruitment MAneuvers and Mechanical Ventilation Guided by EIT in pARDS (REMAV-EIT)

REcruitment MAneuvers and Mechanical Ventilation Guided by EIT in Pediatric Acute Respiratory Distress Syndrome (pARDS)

There is evidence from randomized controlled trials in adult patients with Acute Respiratory Distress Syndrome (ARDS) suggesting that delivering small tidal volumes with adequate levels of Positive End-Expiratory Pressure (PEEP) and a restrictive fluid strategy could improve outcome. However, there are data and common bedside experience that individual patients may or may not respond to interventions, such as escalation of PEEP or positional changes, and there may be a role for a more personalized ventilator strategy.

This strategy could account for the unique individual morphology of lung disease, such as the amount of atelectasis and overdistension as a percentage of total lung tissue, the exact location of atelectasis, and whether positional changes or elevation of PEEP produce lung recruitment or overdistension.

Stepwise Recruitment maneuvers (SRMs) in pARDS improve oxygenation in majority of patients. SRMs should be considered for use on an individualized basis in patients with pARDS should be considered if SpO2 decreases by ≥ 5% within 5 minutes of disconnection during suction or coughing or agitation. If a recruitment maneuver is conducted, a decremental PEEP trial must be done to determine the minimum PEEP that sustains the benefits of the recruitment maneuver.

Electrical impedance tomography (EIT), a bedside monitor to describe regional lung volume changes, displays a real-time cross-sectional image of the lung. EIT is a non-invasive, non-operator dependent, bedside, radiations-free diagnostic tool, feasible in paediatric patients and repeatable. It allows to study ventilation distribution dividing lungs in four Region Of Interest (ROI), that are layers distributed in an anteroposterior direction, and shows how ventilation is distributed in the areas concerned.

EIT measures and calculates other parameters that are related not only to the distribution of ventilation, but also to the homogeneity of ventilation and the response to certain therapeutic maneuvers, such as SRMs or PEEP-application.

Aim of this study is to provide a protocolized strategy to assess optimal recruitment and PEEP setting, tailored on the patients individual response in pARDS.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Intubated and mechanically ventilated children, ageing 1 months-5 years and meeting the PALICC definition for pediatric Acute Respiratory Distress Syndrome (pARDS)
  • Informed Consent signed

Exclusion Criteria: Patients with one or more of the following characteristics:

  • Previous barotrauma (pneumothorax, pneumomediastinum or subcutaneous emphysema)
  • Signs of intracranial hypertension
  • Cyanotic congenital cardiac disease
  • Dorso-lumbar pathologies or other bone pathologies associated with restrictive lung disease (such as scoliosis, kyphosis)
  • Implantable devices not compatible with EIT (such as pace-makers and implantable cardioverter defibrillator)
  • Controindication to positioning the esophageal catheter (surgery, esophageal stenosis)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: T0= Enrollment
mechanical ventilation will be set according to the standard of care criteria
Evaluation of mechanical ventilation and ventilation distribution through EIT. Mechanical ventilation is set by the physician according to clinical protocolized criteria
Active Comparator: T1= guided MV at the end of SRM trial
EIT guided mechanical ventilation will be set

SRMs will be performed with a standardized ventilation protocol. Patient will be sedated, paralyzed and ventilated in pressure controlled mode, FIO2 to obtain SPO2> 92%, RR 25, I:E =1:1.5. Alarm of pressure limit will be set at 35 cmH2O. The ventilator will be equipped with inspiratory and expiratory hold taste. Inspiratory and expiratory occlusion will be held for 5 seconds, data will be stored and analyzed with the ventilator own tool.

Decremental PEEP trial will start if plateau pressure 30 cmH2O will be reached or end inspiratory transpulmonary pressure will exceed 28 cmH2O value. Once reached this level of plateau or transpulmonary pressure, PEEP will be reduced in three steps from 12, 10 and finally to 8 cmH2O every 20 minutes

Other Names:
  • SRMs EIT-guided and DP trial
Mechanical ventilation is set according to EIT measurement
Active Comparator: T2= 24 hours with EIT guided MV
evaluation of mechanical ventilation after 24h EIT-guided ventilation
Evaluation of mechanical ventilation and ventilation distribution through EIT after 24h of ventilation EIT-guided

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Regional Ventilation Delay, RDV (pixels %), at T2 and T0
Time Frame: 1 day
RDV is an index of atelectrauma, supra-distention and in general an inhomogeneous ventilation
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences in Tidal Impedance Distribution,TID (pixels %), at T0, T1 and T2
Time Frame: 1 day
for every breathing cycle, a so-called tidal image is generated and each pixel of represents the difference in impedance between end-inspiration and end-expiration. The median value of each tidal image is calculated for the lung area
1 day
Gravity Centre, GC, differences (pixels %) at T0, T1 and T2
Time Frame: 1 day
it is the weighted mean of row sums obtained from TV image and it indicates ventral-to-dorsal shifts in ventilation distribution due to lung opening and closing
1 day
Respiratory Rate at T0, T1 and T2
Time Frame: 1 day
Respiratory rate (breaths/min)
1 day
FiO2 (%) at T0, T1 and T2
Time Frame: 1 day
FiO2 (%)
1 day
Respiratory compliance at T0, T1 and T2
Time Frame: 1 day
Respiratory System Compliance
1 day
Lung compliance at T0, T1 and T2
Time Frame: 1 day
Clung Lung compliance
1 day
Chest Wall compliance at T0, T1 and T2
Time Frame: 1 day
Chest Wall compliance
1 day
S/F ratio at T0, T1 and T2
Time Frame: 1 day
S/F ratio
1 day
Sistolic Blood Pressure at T0, T1 and T2
Time Frame: 1 day
SBP (mmHg)
1 day
Diastolic Blood Pressure at T0, T1 and T2
Time Frame: 1 day
DBP (mmHg)
1 day
pH at T0, T1 and T2
Time Frame: 1 day
pH
1 day
SpO2 at T0, T1 and T2
Time Frame: 1 day
SpO2 (%)
1 day
PaO2 at T0, T1 and T2
Time Frame: 1 day
PaO2 (mmHg)
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giovanna Chidini, MD, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Estimated)

December 30, 2023

Study Completion (Estimated)

January 30, 2024

Study Registration Dates

First Submitted

September 8, 2022

First Submitted That Met QC Criteria

September 27, 2023

First Posted (Actual)

October 4, 2023

Study Record Updates

Last Update Posted (Actual)

October 4, 2023

Last Update Submitted That Met QC Criteria

September 27, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ARDS

Clinical Trials on EIT measurement

Subscribe